Pharmaceuticals
Israeli health officials call for sanctions on anti-vaxxers as flu morbidity rate rises
Only 17% of Israelis have been vaccinated; health fund CEOs are divided over sanctions versus accessibility.
Israel's biotech moment: How science, data, and geopolitics are converging - opinion
From Auschwitz to Dachau: How a pharmacist became central to Nazi camp medical crimes - study
EU Council and Parliament reach agreement to overhaul drug rules, speed patient access
Israeli gas sensor spots ‘mirror’ molecules, opening path to breath-based diagnostics
By detecting subtle structural differences in volatile compounds, the sensors could power non-invasive breath tests for diseases such as lung cancer or diabetes.
Novo Nordisk advances amycretin to late-stage trial after positive diabetes weight-loss results
Novo Nordisk’s experimental drug amycretin shows strong results in its mid-stage trial, helping type 2 diabetes patients lose up to 14.5% of their body weight.
Teva seeks startups to help solve global pharmaceutical challenges
Called Teva Rise, it aims to accelerate innovations such as AI, digital health, smart manufacturing and biotech
Trump warns pharmaceutical tariffs could reach 200%, gives 'a year to get their act together'
US President Donald Trump plans to implement a 200% tariff rate on pharmaceuticals, while he also announced tariffs on semiconductors and copper.
Israel’s healthcare workforce lags behind OECD averages despite growth in doctors and nurses
Despite an increase in medical professionals, Israel’s healthcare workforce remains below the OECD average, highlighting ongoing challenges.
Teva share price struggles to recover following $6 billion market loss
The financial results were actually positive, at the higher end of analysts' forecasts, but profit guidance for 2025 disappointed the market.
Israel on the pharma frontier: How AION Labs is incubating the next drug development breakthrough
The Inside Israeli Innovation Podcast: Season 2, Episode 43.
Immunai and Teva partner to innovate new cancer, immunology therapies
The collaboration between the two companies reflects ongoing efforts to enhance drug development, the CEO of Immunai said.
Israeli mapping company ImmunAI partners with AstraZeneca
The Israeli-American unicorn company ImmunAI has signed a multi-year cooperation agreement with the pharmaceutical giant AstraZeneca for the advanced optimization of clinical trials.
Immunai, AstraZeneca collaborate to optimize cancer clinical trials
Under the terms of the agreement, AstraZeneca will leverage Immunai’s platform and machine learning capabilities to inform certain oncology clinical trials.
Kahun’s pharma-focused AI agent: Bridging medical knowledge and patient care
Kahun’s new AI Agent is revolutionizing healthcare by providing real-time, patient-specific medical insights, helping doctors stay updated on pharmaceutical developments while improving patient care.
